臺灣學術機構典藏系統 (Taiwan Academic Institutional Repository, TAIR)

???ui.leftmenu.abouttair???
	???ui.leftmenu.explanation???

???ui.leftmenu.bartitle???
	Repositories
	Author
	Title
	Date
	???ui.leftmenu.statisticschart???
	???ui.leftmenu.realtimefacts???
	???ui.leftmenu.trend???

???index.news???
	2019臺灣學術機構典藏研討會
	機構典藏系統RC7版本已發佈

???ui.leftmenu.copyrighttitle???
	???ui.leftmenu.copyrightpublisher???
	???ui.leftmenu.copyrightconference???

???ui.leftmenu.link???
	機構典藏計畫網站
	ROAR
	OpenDOAR
	SHERPA
	OAIster
	JAIRO
	Ira
	DSPACE
	RWWR
	臺大學術典藏NTU Scholars

"yen shen lu"???jsp.browse.items-by-author.description???

???jsp.browse.items-by-author.back???
???jsp.browse.items-by-author.order1???	???jsp.browse.items-by-author.order2???

Showing items 126-149 of 149 (6 Page(s) Totally)
<< < 1 2 3 4 5 6
View [10|25|50] records per page

Institution	Date	Title	Author
臺大學術典藏	2020-05-25T06:51:44Z	Ribociclib (RIB) + non-steroidal aromatase inhibitor (NSAI) + goserelin in premenopausal Asian women with hormone-receptor-positive (HR+), HER2-negative (HER2-) advanced breast cancer (ABC): Results from the randomized phase III MONALEESA-7 study	Im S.-A;Sohn J;Tripathy D;Chow L;Lee K.S;Jung K.H;Babu G;Im Y.-H;El Saghir N;Liu M.-C;Diaz-Padilla I;Alam J;Kong O;Miller M;Yen-Shen Lu; Im S.-A; Sohn J; Tripathy D; Chow L; Lee K.S; Jung K.H; Babu G; Im Y.-H; El Saghir N; Liu M.-C; Diaz-Padilla I; Alam J; Kong O; Miller M; YEN-SHEN LU
臺大學術典藏	2020-05-25T06:51:44Z	Tamoxifen (TAM) or a non-steroidal aromatase inhibitor (NSAI) with ribociclib (RIB) in premenopausal patients (pts) with hormone receptor-positive (HR+), HER2-negative (HER2-) advanced breast cancer (ABC): MONALEESA-7 subgroup analysis	Bardia A;Campos-Gomez S;Hurvitz S.A;Yen-Shen Lu;Im S.-A;Franke F;Chow L;Wheatley-Price P;Melo Cruz F;Alam J;Kong O;Diaz-Padilla I;Miller M;Tripathy D.; Bardia A; Campos-Gomez S; Hurvitz S.A; YEN-SHEN LU; Im S.-A; Franke F; Chow L; Wheatley-Price P; Melo Cruz F; Alam J; Kong O; Diaz-Padilla I; Miller M; Tripathy D.
臺大學術典藏	2020-05-25T06:51:44Z	Oral paclitaxel and HM30181A demonstrate clinical activity in metastatic breast cancer (MBC) patients	Dai M.-S;Chao T.-Y;Chao T.-C;Chiu C.-F;Yen-Shen Lu;Shiah H.-S;Wu Y.-Y;Gerald Fetterly G;Hung N;Cutler D.L;Kwan R;Douglas Kramer D;Chan W.-K;Hung T.; Dai M.-S; Chao T.-Y; Chao T.-C; Chiu C.-F; YEN-SHEN LU; Shiah H.-S; Wu Y.-Y; Gerald Fetterly G; Hung N; Cutler D.L; Kwan R; Douglas Kramer D; Chan W.-K; Hung T.
臺大學術典藏	2020-05-25T06:51:43Z	Neratinib after trastuzumab-based adjuvant therapy in patients from Asia with early stage HER2-positive breast cancer	Iwata H;Masuda N;Kim S.-B;Inoue K;Rai Y;Fujita T;Chiu J;Ohtani S;Takahashi M;Miyaki T;Yen-Shen Lu;Xu B;Yap Y.S;Bustam A;Yao B;Zhang B;Bryce R;Chan A.; Iwata H; Masuda N; Kim S.-B; Inoue K; Rai Y; Fujita T; Chiu J; Ohtani S; Takahashi M; Miyaki T; YEN-SHEN LU; Xu B; Yap Y.S; Bustam A; Yao B; Zhang B; Bryce R; Chan A.
臺大學術典藏	2020-05-25T06:51:43Z	Alpelisib for PIK3CA-mutated, hormone receptor-positive advanced breast cancer	Andr? F;Ciruelos E;Rubovszky G;Campone M;Loibl S;Rugo H.S;Iwata H;Conte P;Mayer I.A;Kaufman B;Yamashita T;Yen-Shen Lu;Inoue K;Takahashi M;P?Pai Z;Longin A.-S;Mills D;Wilke C;Hirawat S;Juric D.; Andr? F; Ciruelos E; Rubovszky G; Campone M; Loibl S; Rugo H.S; Iwata H; Conte P; Mayer I.A; Kaufman B; Yamashita T; YEN-SHEN LU; Inoue K; Takahashi M; P?pai Z; Longin A.-S; Mills D; Wilke C; Hirawat S; Juric D.
臺大學術典藏	2020-05-25T06:51:42Z	Ribociclib and Endocrine Therapy in Breast Cancer. Reply	Im S.-A;Yen-Shen Lu;Tripathy D.; Im S.-A; YEN-SHEN LU; Tripathy D.
臺大學術典藏	2020-05-25T06:51:42Z	Treating HR+/HER2? breast cancer in premenopausal Asian women: Asian Breast Cancer Cooperative Group 2019 Consensus and position on ovarian suppression	Yeo W;Ueno T;Lin C.-H;Liu Q;Lee K.-H;Leung R;Naito Y;Park Y.H;Im S.-A;Li H;Yap Y.S;Yen-Shen Lu;The Asian Breast Cancer Cooperative Group; Yeo W; Ueno T; Lin C.-H; Liu Q; Lee K.-H; Leung R; Naito Y; Park Y.H; Im S.-A; Li H; Yap Y.S; YEN-SHEN LU; The Asian Breast Cancer Cooperative Group
臺大學術典藏	2020-05-25T06:51:42Z	PI3K inhibitor provides durable response in metastatic metaplastic carcinoma of the breast: A hidden gem in the BELLE-4 study	Yang M.-H;Chen I.-C;Yen-Shen Lu; Yang M.-H; Chen I.-C; YEN-SHEN LU
臺大學術典藏	2020-05-25T06:51:42Z	Insights into Breast Cancer in the East vs the West: A Review	Yap Y.-S;Yen-Shen Lu;Tamura K;Lee J.E;Ko E.Y;Park Y.H;Cao A.-Y;Lin C.-H;Toi M;Wu J;Lee S.-C.; Yap Y.-S; YEN-SHEN LU; Tamura K; Lee J.E; Ko E.Y; Park Y.H; Cao A.-Y; Lin C.-H; Toi M; Wu J; Lee S.-C.
臺大學術典藏	2020-05-25T06:51:42Z	Contrasting Epidemiology and Clinicopathology of Female Breast Cancer in Asians vs the US Population	YEN-SHEN LU; Asian Breast Cancer Cooperative Group; Cheng A.-L; Huang C.-S; Hu F.-C; Tan B; Han W; Leung R; Huang S.-M; Li H; Kwong A; Ueno T; Yeo W; Naito Y; Im S.-A; Lee K.-H; Yap Y.S; Lin C.-H; Lin C.-H;Yap Y.S;Lee K.-H;Im S.-A;Naito Y;Yeo W;Ueno T;Kwong A;Li H;Huang S.-M;Leung R;Han W;Tan B;Hu F.-C;Huang C.-S;Cheng A.-L;Yen-Shen Lu;Asian Breast Cancer Cooperative Group
臺大學術典藏	2020-05-25T06:51:41Z	Mortality of Pregnancy Following Breast Cancer Diagnoses in Taiwanese Women	Chuang S.-C;Lin C.-H;Yen-Shen Lu;Hsiung C.A.; Chuang S.-C; Lin C.-H; YEN-SHEN LU; Hsiung C.A.
臺大學術典藏	2020-05-25T06:51:41Z	Immunofluorescence can assess the efficacy of mTOR pathway therapeutic agent Everolimus in breast cancer models	Kuo C.-T;Chen C.-L;Li C.-C;Huang G.-S;Ma W.-Y;Hsu W.-F;Lin C.-H;Yen-Shen Lu;Wo A.M.; Kuo C.-T; Chen C.-L; Li C.-C; Huang G.-S; Ma W.-Y; Hsu W.-F; Lin C.-H; YEN-SHEN LU; Wo A.M.
臺大學術典藏	2020-05-25T06:51:41Z	Disparity in Tumor Immune Microenvironment of Breast Cancer and Prognostic Impact: Asian Versus Western Populations	Lin C.-H.; Lu T.-P; Kuo C.-W; Chen I.-C; Chao M; Chen C.-H;Yen-Shen Lu;Cheng A.-L;Huang C.-S;Kuo W.-H;Wang M.-Y;Chao M;Chen I.-C;Kuo C.-W;Lu T.-P;Lin C.-H.; Chen C.-H; YEN-SHEN LU; Cheng A.-L; Huang C.-S; Kuo W.-H; Wang M.-Y
臺大學術典藏	2020-05-25T06:51:40Z	Pan-Asian adapted ESMO Clinical Practice Guidelines for the management of patients with early breast cancer: a KSMO-ESMO initiative endorsed by CSCO, ISMPO, JSMO, MOS, SSO and TOS	Park Y.H;Senkus-Konefka E;Im S.-A;Pentheroudakis G;Saji S;Gupta S;Iwata H;Mastura M.Y;Dent R;Yen-Shen Lu;Yin Y;Smruti B.K;Toyama T;Malwinder S;Lee S.C;Tseng L.-M;Kim J.H;Kim T.-Y;Suh K.J;Cardoso F;Yoshino T;Douillard J.-Y.; Park Y.H; Senkus-Konefka E; Im S.-A; Pentheroudakis G; Saji S; Gupta S; Iwata H; Mastura M.Y; Dent R; YEN-SHEN LU; Yin Y; Smruti B.K; Toyama T; Malwinder S; Lee S.C; Tseng L.-M; Kim J.H; Kim T.-Y; Suh K.J; Cardoso F; Yoshino T; Douillard J.-Y.
臺大學術典藏	2019	Overall survival with ribociclib plus endocrine therapy in breast cancer	Tripathy D.; Hurvitz S; Im S.-A; YEN-SHEN LU; Im S.-A;Yen-Shen Lu;Bardia A;Harbeck N;Colleoni M;Franke F;Chow L;Sohn J;Lee K.-S;Campos-Gomez S;Villanueva-Vazquez R;Jung K.-H;Chakravartty A;Hughes G;Gounaris I;Rodriguez-Lorenc K;Taran T;Hurvitz S;Tripathy D.; Rodriguez-Lorenc K; Taran T; Gounaris I; Chakravartty A; Hughes G; Jung K.-H; Villanueva-Vazquez R; Campos-Gomez S; Lee K.-S; Sohn J; Chow L; Bardia A; Harbeck N; Colleoni M; Franke F
臺大學術典藏	2018-09-10T06:52:59Z	Dose variation and regimen modification of adjuvant chemotherapy in daily practice affect survival of stage I–II and operable stage III Taiwanese breast cancer patients	Sung-Hsin Kuo; Huang-Chun Lien; San-Lin You; Yen-Shen Lu; Ching-Hung Lin; T.-Zui Chen; Chiun-Sheng Huang; CHIUN-SHENG HUANG; Sung-Hsin Kuo; CHING-HUNG LIN; HUANG-CHUN LIEN
臺大學術典藏	2018	Association of pregnancy and mortality in women diagnosed with breast cancer: A Nationwide Population Based Study in Taiwan	Chuang S.-C;Lin C.-H;Yen-Shen Lu;Hsiung C.A.; Chuang S.-C; Lin C.-H; YEN-SHEN LU; Hsiung C.A.
臺大學術典藏	2018	A Phase I/II study of the combination of lapatinib and oral vinorelbine in HER2-positive metastatic breast cancer	Chen T.W.-W; Yeh D.-C; Chao T.-Y; Lin C.-H; Chow L.W.-C; Chang D.-Y; Hsieh Y.-Y; Huang S.-M; Cheng A.-L; YEN-SHEN LU; Taiwan Breast Cancer Consortium; Chen T.W.-W;Yeh D.-C;Chao T.-Y;Lin C.-H;Chow L.W.-C;Chang D.-Y;Hsieh Y.-Y;Huang S.-M;Cheng A.-L;Yen-Shen Lu;Taiwan Breast Cancer Consortium
臺大學術典藏	2012	Dynamics of circulating endothelial cells and endothelial progenitor cells in breast cancer patients receiving cytotoxic chemotherapy	Cheng A.-L.;Yen-Shen Lu;Hsu C;Huang S.-M;Yang S.-H;Chen T.-J;Shau W.-Y;Lin C.-H;Kuo Y.-H; Kuo Y.-H; Lin C.-H; Shau W.-Y; Chen T.-J; Yang S.-H; Huang S.-M; Hsu C; YEN-SHEN LU; Cheng A.-L.
中國醫藥大學	2011	Prognostic molecular markers in women aged 35 years or younger with breast cancer: is there a difference from the older patients	(Ching-Hung Lin); (Yen-Shen Lu); (Chiun-Sheng Huang); (Kuan-Ting Kuo); (Chung-Chieh Wang); (San-Lin You); 林柏翰(Po-Han Lin); (Dwan-Ying Chang); (Wen-Hung Kuo); (King-Jen Chang); (Ann-Lii Cheng)*
臺大學術典藏	2011	Lack of efficacy to systemic chemotherapy for treatment of metaplastic carcinoma of the breast in the modern era	Cheng A.L.; YEN-SHEN LU; Kuo W.H; Chen I.C; Lin C.H; Huang C.S; Lien H.C; Hsu C; Chen I.C;Lin C.H;Huang C.S;Lien H.C;Hsu C;Kuo W.H;Yen-Shen Lu;Cheng A.L.
臺大學術典藏	2010	Fractionated evaluation of immunohistochemical hormone receptor expression enhances prognostic prediction in breast cancer patients treated with tamoxifen as adjuvant therapy	Lin C.-H;Lien H.-C;Hu F.-C;Yen-Shen Lu;Kuo S.-H;Wu L.-C;You S.-L;Cheng A.-L;Chang K.-J;Huang C.-S.; Lin C.-H; Lien H.-C; Hu F.-C; YEN-SHEN LU; Kuo S.-H; Wu L.-C; You S.-L; Cheng A.-L; Chang K.-J; Huang C.-S.
臺大學術典藏	2010	Vinorelbine plus 24-hour infusion of high-dose 5-fluorouracil and leucovorin as effective palliative chemotherapy for breast cancer patients with acute disseminated intravascular coagulation	Lin P.-H;Yen-Shen Lu;Lin C.-H;Chang D.-Y;Huang C.-S;Cheng A.-L;Yeh K.-H.; Lin P.-H; YEN-SHEN LU; Lin C.-H; Chang D.-Y; Huang C.-S; Cheng A.-L; Yeh K.-H.
臺大學術典藏	2008	Down-regulation of phospho-Akt is a major molecular determinant of bortezomib-induced apoptosis in hepatocellular carcinoma cells	Cheng A.-L.; Huang S.-Y; YEN-SHEN LU; Yeh K.-H; Yeh P.-Y; Chen K.-F; Chen K.-F;Yeh P.-Y;Yeh K.-H;Yen-Shen Lu;Huang S.-Y;Cheng A.-L.

Showing items 126-149 of 149 (6 Page(s) Totally)
<< < 1 2 3 4 5 6
View [10|25|50] records per page

	English \| 正體中文 \| 简体中文 \| 2825920
	???header.visitor??? : 31402851 ???header.onlineuser??? : 1132 ???header.sponsordeclaration???